Home » Stocks » VRTX » Financials

Vertex Pharmaceuticals, Inc. (VRTX)

Stock Price: $213.00 USD 0.10 (0.05%)
Updated May 11, 2021 4:00 PM EDT - Market closed
After-hours: $212.99 -0.01 (-0.01%) May 11, 6:10 PM

Income Statement (Annual)

Numbers in millions USD. Fiscal year is January - December.
Year202020192018201720162015201420132012201120102009200820072006
Revenue6,2064,1633,0482,4891,7021,0325801,2121,5271,411143102176199216
Revenue Growth49.07%36.59%22.46%46.2%64.89%77.86%-52.11%-20.63%8.25%883.91%40.71%-41.94%-11.81%-8.02%-
Cost of Revenue73654841027521012560.9913028080.5112.7314.2015.6913.9012.17
Gross Profit5,4693,6152,6382,2141,4929085191,0821,2471,33013187.69160185204
Selling, General & Admin77065855849643337730535643340118813010178.5550.35
Research & Development1,8301,7551,4161,3251,048996856882766708637550517519379
Other Operating Expenses0.000.0028.822701.262.2150.934531.841081.5021.234.327.123.65
Operating Expenses2,6002,4132,0032,0901,4821,3751,2121,6921,2001,216827702623605433
Operating Income2,8691,2026351239.94-467-692-61046.73114-696-614-463-420-229
Interest Expense / Income58.1558.5072.4769.3081.4384.2172.8622.9315.0437.6819.2813.1913.472.297.96
Other Expense / Income-306-251-47.36-10223.89-25.13-33.68-65.4813927.3039.2714.97-16.33-30.80-30.10
Pretax Income3,1171,395610156-95.39-526-732-567-10748.84-755-642-460-391-207
Income Tax405218-1,487-10716.6730.386.96-122-0.2819.27-----
Net Income2,7121,1772,097263-112-556-739-445-10729.57-755-642-460-391-207
Shares Outstanding (Basic)260257254249245241235225212205200173141129113
Shares Outstanding (Diluted)263261259253245241235225215209200173141129113
Shares Change1.21%0.96%2.18%1.71%1.4%2.55%4.62%6.11%3.44%2.24%15.67%23.27%8.97%13.92%-
EPS (Basic)10.444.588.241.06-0.46-2.31-3.14-1.98-0.500.14-3.77-3.71-3.27-3.03-1.83
EPS (Diluted)10.294.518.091.04-0.46-2.31-3.14-1.98-0.500.14-3.77-3.71-3.27-3.03-1.83
EPS Growth128.16%-44.25%677.88%------------
Free Cash Flow Per Share11.525.824.623.000.73-1.70-2.65-0.500.930.53-3.36-2.60-1.84-2.21-0.49
Gross Margin88.1%86.8%86.6%88.9%87.6%87.9%89.5%89.3%81.7%94.3%91.1%86.1%91.1%93%94.4%
Operating Margin46.2%28.9%20.8%5.0%0.6%-45.2%-119.3%-50.3%3.1%8.1%-485.5%-602.6%-263.6%-210.9%-105.9%
Profit Margin43.7%28.3%68.8%10.6%-6.6%-53.9%-127.2%-36.7%-7%2.1%-526.3%-630.3%-262%-196.6%-95.6%
FCF Margin48.2%35.9%38.5%30.0%10.5%-39.8%-107.6%-9.2%12.9%7.7%-469.8%-442.7%-147.4%-143.2%-25.4%
Effective Tax Rate13.0%15.6%-------39.4%-----
EBITDA3,2841,56075528747.44-379-595-496-54.08122-705-599-414-362-173
EBITDA Margin52.9%37.5%24.8%11.5%2.8%-36.8%-102.6%-40.9%-3.5%8.6%-491.7%-587.8%-236%-181.7%-80%
EBIT3,1751,453683225-13.96-442-659-545-92.2786.52-735-629-446-389-199
EBIT Margin51.2%34.9%22.4%9.1%-0.8%-42.8%-113.5%-44.9%-6.0%6.1%-512.9%-617.3%-254.3%-195.5%-91.9%

Showing 15 of 26 years

11 more years are available